Tia today announced a $100 million Series B funding round led by Lone Pine Capital with additional participation from investors including Threshold, Define Ventures, Torch Capital, ACME, Compound, Combine, The Helm, Human Ventures, Seae Ventures and Gingerbread Capital.
The round marks one of the largest Series B investments for a healthcare company focused on women, signaling that Tia’s anti-fragmentation approach helps to shift women’s health from “niche” to mass market. This brings Tia’s total funding to $132 million. Read more.
